header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Hip

TWO-STAGE EXCHANGE FOR INFECTION: ARE PROLONGED COURSES OF ANTIBIOTIC THERAPY NECESSARY?

The International Hip Society (IHS), London, England, September 2017



Abstract

The management of periprosthetic joint infection is challenging and the duration of systemic antibiotic therapy whether it be during the interval phase or after reimplantation of a new prosthesis is controversial. We report our experience of managing chronic periprosthetic infection of the hip by the two stage exchange procedure.

Patients who were scheduled to undergo a two stage revision for chronic periprosthetic infection of the hip were identified from our prospective database.

Of 425 patients with microbiologically proven periprosthetic infection, 369 (87%) underwent a two stage procedure, leaving 56 patients who did not proceed to reimplantation. 41 of these were clinically infection free but for personal or medical reasons did not proceed. The remaining 15 had persistent infection. The mean age at the time of the first stage was 68 years (26 – 92 yrs). 256 (61%) patients were alive for review. The mean time between stages was 6.3 months with a mean follow up after the second stage was 65 months (range 5 to 276 months).

The success rate of a single 1st stage debridement, confirmed by negative cultures at the time of second stage reimplantation was 94%. 19 patients underwent a repeat 1st stage debridement and were classed as failures of the 1st stage. At the time of final review, 340 (92%) patients were deemed infection free out of those who had completed a 2 stage exchange.

The duration of systemic antibiotic treatment after both the 1st and 2nd stages was divided into <48 hrs and >48 hours. There was no significant difference in the success of the 1st stage procedure in patients who received < 48 hours (48% of the patients) as opposed to > 48 hours (p = 0.98, Chi Squared Test, Relative Risk 1.009). Similarly there was no difference in the overall success of the two stage procedure irrespective of the duration of antibiotic therapy with 76% of patients receiving <48hrs of antibiotics after the second stage.

Aggressive surgical debridement together with targeted local and short term systemic antibiotic therapy should be the mainstay of treatment in two stage revision surgery.


Email: